Artia Global Partners’s Insmed INSM Stock Holding History

Artia Global Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.8M	Sell	589,052 -39,660	-6%	-$4.8M	11.59%	2
2026 Q1	$103M	Sell	628,712 -53,500	-8%	-$8.23M	20.59%	1
2025 Q4	$119M	Sell	682,212 -50,000	-7%	-$9.12M	16.82%	1
2025 Q3	$105M	Sell	732,212 -20,500	-3%	-$2.51M	16.71%	1
2025 Q2	$75.8M	Buy	752,712 +434,473	+137%	+$33.2M	18.23%	2
2025 Q1	$24.3M	Buy	318,239 +150,300	+89%	+$11.5M	6.15%	6
2024 Q4	$11.6M	Buy	167,939 +115,000	+217%	+$8.28M	4.14%	13
2024 Q3	$3.86M	Sell	52,939 -497	-0.9%	-$36.7K	1.05%	19
2024 Q2	$3.58M	Sell	53,436 -64,800	-55%	-$2.51M	0.69%	21
2024 Q1	$3.21M	Buy	118,236 +43,300	+58%	+$1.21M	0.64%	21
2023 Q4	$2.32M	Buy	+74,936	New	+$1.94M	0.68%	19

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Artia Global Partners's INSM Position: Q2 2026 in Review

Artia Global Partners reduced its Insmed (INSM) stake by 6.3% in Q2 2026, selling an estimated $4.8M and leaving 589,052 shares worth $62.8M. The position accounts for 11.59% of the portfolio, ranked #2.

Artia Global Partners first reported a position in INSM in Q4 2023 and has held it in 11 quarters since. The position peaked at $119M in Q4 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Artia Global Partners held 589,052 shares of Insmed worth $62.8M as of Q2 2026.
Artia Global Partners sold 39,660 Insmed shares in Q2 2026, an estimated $4.8M.
Insmed made up 11.59% of Artia Global Partners's portfolio in Q2 2026, its #2 holding.
Artia Global Partners first reported a position in Insmed in Q4 2023 and has held it in 11 quarters since.
Artia Global Partners's Insmed position peaked at $119M in Q4 2025.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Artia Global Partners's 13F filing for Q2 2026, filed 14 Aug 2026.